Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 2/20 | 0.38 |
| ▸ | CCR5 | P51681 | 2/20 | 0.37 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
| ▸ | XDH | P47989 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | F2RL1 | P55085 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4642066 | 0.92 | CCR5 (0.39) | FPR2CCR5LRRK2XDHMAOA | |
| SCHEMBL5597241 | 0.90 | SLC6A4 (0.39) | CCR5MAOBSLC6A4SMN1; SMN2 | |
| SCHEMBL5597310 | 0.83 | FPR2 (0.44) | FPR2XDHMAOB | |
| SCHEMBL5597418 | 0.80 | MRGPRX4 (0.36) | MAPTSLC6A4SMN1; SMN2 | |
| SCHEMBL4640765 | 0.78 | FPR2 (0.40) | FPR2NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4642685 | 0.77 | FPR2 (0.47) | FPR2LRRK2MAPTNPC1HTT | |
| SCHEMBL4642228 | 0.77 | FPR2 (0.44) | FPR2XDHMAPT | |
| SCHEMBL2352269 | 0.74 | CYP19A1 (0.43) | CCR5LRRK2 | |
| SCHEMBL4642508 | 0.73 | MRGPRX4 (0.39) | MAPTSLC6A4HTTSMN1; SMN2 | |
| SCHEMBL5597305 | 0.73 | FPR2 (0.40) | FPR2NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1804819-A4 | USE OF AROMATASE INHIBITORS FOR ENDOMETRIAL THINNING IN PREPARATION FOR SURGICAL PROCEDURES ON THE ENDOMETRIAL CAVITY AND UTERUS | UNIV WAYNE STATE (US) | 2007-12-12 | — | — | EP | disclosed |
| EP-1804819-A2 | USE OF AROMATASE INHIBITORS FOR ENDOMETRIAL THINNING IN PREPARATION FOR SURGICAL PROCEDURES ON THE ENDOMETRIAL CAVITY AND UTERUS | WAYNE STATE UNIVERSITY (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1381431-B1 | AROMATASE INHIBITION TO ENHANCE IMPLANTATION RATE | ARES TRADING SA (CH) | 2007-06-06 | — | — | EP | disclosed |
| WO-2006041939-A2 | USE OF AROMATASE INHIBITORS FOR ENDOMETRIAL THINNING IN PREPARATION FOR SURGICAL PROCEDURES ON THE ENDOMETRIAL CAVITY AND UTERUS | WAYNE STATE UNIVERSITY (US) | 2006-04-20 | — | — | WO | disclosed |
| EP-1492515-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AROMATASE INHIBITOR AND AN ESTROGEN SUITABLE FOR HORMONE REPLACEMENT THERAPY FOR A MALE | JENCAP RESEARCH LTD. (CA) | 2005-01-05 | — | — | EP | disclosed |
| WO-2003082254-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AROMATASE INHIBITOR AND AN ESTROGEN SUITABLE FOR HORMONE REPLACEMENT THERAPY FOR A MALE | JENCAP RESEARCH LTD. (CA) | 2003-10-09 | — | — | WO | disclosed |